 TEL AVIV, Israel--BUSINESS WIRE--- IRME--IR-Med OTC: IRME Company or the Company is proud to announce a series of corporate updates to its investors regarding the medical, financial, and corporate status of the company. Amongst other things, IR-Med announces that starting H1 of 2022 the Company will initiate a usability test to demonstrate the capabilities of its proprietary PressureSafe device. The Company updates that it has received an IRB-Helsinki Committee approval from one of Israels 